Update Venetoclax in CLL
Acalabrutinib
(Update) Acalabrutinib in CLL and MCL
Obinutuzumab
UpToDate
NCCN COVID-19 Resources Page
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
NCCN Guidelines for Patients for CLL